
Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz
1/14/2026
0:00
7:39
AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
More episodes from "TechCrunch Startup News"



Don't miss an episode of “TechCrunch Startup News” and subscribe to it in the GetPodcast app.







